Question 1

Am I eligible for this trial based on my current treatment and health status?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Therapeutic RSK1 Targeting in Myeloid Malignancies clinical trial (NCT07379125). Contact the study team or your healthcare provider for specific answers.

Question 2

What are the potential side effects of PMD-026 that I should be aware of?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Therapeutic RSK1 Targeting in Myeloid Malignancies clinical trial (NCT07379125). Contact the study team or your healthcare provider for specific answers.

Question 3

How does this treatment compare to my current options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Therapeutic RSK1 Targeting in Myeloid Malignancies clinical trial (NCT07379125). Contact the study team or your healthcare provider for specific answers.

Question 4

What will my participation involve in terms of visits and medication schedule?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Therapeutic RSK1 Targeting in Myeloid Malignancies clinical trial (NCT07379125). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Therapeutic RSK1 Targeting in Myeloid Malignancies clinical trial (NCT07379125). Contact the study team or your healthcare provider for specific answers.

Question 6

How will the effectiveness of PMD-026 be measured during the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Therapeutic RSK1 Targeting in Myeloid Malignancies clinical trial (NCT07379125). Contact the study team or your healthcare provider for specific answers.

What this study is about